[ad_1]
SAM immediately informed the coordinator to temporarily suspend vaccination with this batch of vaccine. The State Agency for the Control of Medicines (IARC) was instructed to investigate before Wednesday night whether the vaccine had been affected by temperature fluctuations during transport. SAM provided the data to the Pfizer representative office in Lithuania for the manufacturer to conclude whether the fluctuations found did not affect the quality of the vaccine.
As early as Wednesday, conclusions are expected from IWT and Pfizer’s representative office in Lithuania on whether additional use of these doses of vaccine is possible, according to the SAM report. The aforementioned shipment contained 4,680 doses of COVID-19 vaccine: 2,340 doses of vaccine for the Kaunas and Panevėžys regions.
According to the preliminary assessment of the Pfizer representative office in Lithuania, the temperature drift during transport was within the allowed limits and had no effect on the vaccines.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
